HORIZON PHACOEMULSIFICATION SYSTEM, MODEL HZN-2030

Unit, Phacofragmentation

AMERICAN OPTISURGICAL, INC.

The following data is part of a premarket notification filed by American Optisurgical, Inc. with the FDA for Horizon Phacoemulsification System, Model Hzn-2030.

Pre-market Notification Details

Device IDK020527
510k NumberK020527
Device Name:HORIZON PHACOEMULSIFICATION SYSTEM, MODEL HZN-2030
ClassificationUnit, Phacofragmentation
Applicant AMERICAN OPTISURGICAL, INC. 25501 ARCTIC OCEAN Lake Forest,  CA  92630
ContactNanette Canepa
CorrespondentNanette Canepa
AMERICAN OPTISURGICAL, INC. 25501 ARCTIC OCEAN Lake Forest,  CA  92630
Product CodeHQC  
CFR Regulation Number886.4670 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2002-02-19
Decision Date2002-07-09
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.